| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.007 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |